Bio-Works Technologies AB

BIOWKS · Nasdaq Stockholm · Healthcare

3.03SEK −1.0%last day

Price as of 1 October 2026

The price over the past year, with dividends: +13.1%

Performance

1 month

−4.7%

1 year

+13.1%

3 years, per year

−29.2%

5 years, per year

−31.3%

Largest fall, 3 years

−97.2%

Below the peak now

−89.4%

Volatility, 1 year

64.8%

Return with dividends reinvested.

Key figures

P/E

132.7

P/B

5.5

Dividend yield

0.0%

Return on equity

+4.2%

Net margin

+2.5%

Market value

30 m USD

Quality, value and trend

Where Bio-Works Technologies stands against every Nordic stock today. 100 is best.

Quality68

Profitability and a sound balance sheet over time. Better than 68% of Nordic stocks.

Value19

The price measured against earnings, assets and cash flow. Better than 19% of Nordic stocks.

Trend43

The price development over the past year. Better than 43% of Nordic stocks.

Combined35

Quality, value and trend together. Better than 35% of Nordic stocks.

About Bio-Works Technologies

Bio-Works Technologies AB is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 32 employees.

Bio-Works Technologies AB (publ), together with its subsidiaries, engages in the manufactures and sale of chromatography resins for the purification of biopharmaceuticals in Sweden. The company offers affinity and activated resin, hydrophobic interaction chromatography (HIC) resins, GoBio Mini and GoBio prepacked columns, ion exchange chromatography (IEX) resin, immobilized metal-ion affinity chromatography (IMAC) resin, size exclusion chromatography (SEC) resins, HTPD formats, screening kits, and desalting columns; and WorkBeads chromatography resins. Its products are used in antibodies, his-tagged proteins, proteins, peptides, oligonucleotides, and viruses and vaccines applications.

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis